Evidence map›Paper›PMID 40783907›Full record

ArticleMolecular diversity2026

Mol-SGGI: an attention-guided comprehensive molecular multi-representation learning and adaptive fusion framework for molecular property prediction.

Lei Ma, Chunyun Pu, Dangguo Shao, Sanli Yi

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lei MaFaculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Chunyun PuFaculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.
Dangguo ShaoFaculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China. 3218422967@qq.com.
Sanli YiFaculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular property prediction is pivotal for drug discovery, offering significant potential to accelerate development and reduce costs. With the rapid development of artificial intelligence, molecular representation methods have become increasingly diversified. However, existing methods still have obvious deficiencies in the comprehensiveness of molecular representation and the effectiveness of feature fusion: single representation methods often can only capture part of a molecule's features, while multi-representation methods focus on limited combinations and use simple fusion strategies. To address these issues, we propose Mol-SGGI, a comprehensive multi-representation learning framework that integrates four molecular representations: sequences, 2D graph structures, 3D geometric structures, and images. For each representation, we design specialized modules for extracting features and introduce appropriate attention mechanisms in each module to effectively capture the structural and chemical information of the molecule. Additionally, we propose an attention-guided adaptive weighted fusion module, which achieves multimodal feature alignment through contrastive learning and dynamically adjusts fusion weights. Experimental results on eight molecular property prediction tasks show that our model significantly outperforms the majority of existing methods.

Indexed as

Drug DiscoveryMachine LearningAlgorithmsAttention MechanismFeature fusionMolecular property predictionMulti-representation learning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.